| About Us |
|
|
|
| Our Network |
 |
|
|
| Home > About Us > How We Work |
|
|
|
| How We Work |
|
Clinexa is a SMO that is a class apart! We believe that the best value an SMO can offer
is through complimenting the Sponsor and/or CRO in providing a platform for seamless project management at the
investigative site. The following characteristics about Clinexa differentiate us as a SMO partner that you can fully
trust your study with.
Clinexa has its own well trained and constantly expanding CRC pool. CRCs are deployed
at the investigative sites based upon their demographics, prior experience with the same site, same therapeutic
area, same sponsor, etc. The CRCs go through a training curriculum that equips them to efficiently support the
study at the investigative site. Adequate back-up CRCs are available when the need arises. Contingency plans are
created at study start up so risk due to a CRC becoming unavailable at a short notice can be mitigated.
Clinexa designates a project manager for each study. The CRCs involved in a particular
study report directly to the project manager. The project manager is an active link between the investigative site
and the CRO/Sponsor. The Project Manager makes sure that the CRCs are executing the day to day tasks as expected by
CRO/Sponsor and queries are resolved with minimum delays. The project manager also makes sure that the study is
conducted at the investigative site with the highest quality and ethical standards. A communication plan is
developed by the project manager at study start up and shared with the CRO/Sponsor. Clinexa CRCs and Project Manager
make sure that the CRAs effort and time utilization at the site is highly efficient.
We develop our investigator network on the guidelines of the NIH-Roadmap of Medical
Research for a better translation of scientific discovery into clinical practice. We see clinical research as a
vital sector of translational medicine and a bottle neck of drug discovery which needs the re-engineering measures
for an efficient outcome. Our inventory of network investigators belong to a whole spectrum of therapeutic areas
which have the capability of investigating the blockbuster drugs as well as the nichebuster drugs developed as
personalized therapies in the evolving theragnostic model.
|
|
